Raymond James Financial Services Advisors Inc. raised its position in Cigna Corporation (NYSE:CI) by 5.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,478 shares of the health services provider’s stock after purchasing an additional 1,169 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Cigna Corporation were worth $4,015,000 as of its most recent filing with the SEC.

A number of other large investors have also recently modified their holdings of the business. Saratoga Research & Investment Management bought a new stake in shares of Cigna Corporation during the third quarter worth $112,000. Riverhead Capital Management LLC increased its position in shares of Cigna Corporation by 159.3% during the second quarter. Riverhead Capital Management LLC now owns 5,511 shares of the health services provider’s stock worth $923,000 after acquiring an additional 3,386 shares in the last quarter. Pacer Advisors Inc. increased its position in shares of Cigna Corporation by 3.0% during the second quarter. Pacer Advisors Inc. now owns 5,581 shares of the health services provider’s stock worth $934,000 after acquiring an additional 165 shares in the last quarter. Norinchukin Bank The increased its position in shares of Cigna Corporation by 6.4% during the second quarter. Norinchukin Bank The now owns 17,766 shares of the health services provider’s stock worth $2,974,000 after acquiring an additional 1,062 shares in the last quarter. Finally, Seven Eight Capital LP increased its position in shares of Cigna Corporation by 504.4% during the second quarter. Seven Eight Capital LP now owns 27,200 shares of the health services provider’s stock worth $4,553,000 after acquiring an additional 22,700 shares in the last quarter. 89.65% of the stock is owned by hedge funds and other institutional investors.

Cigna Corporation (CI) opened at $200.72 on Thursday. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. Cigna Corporation has a 1-year low of $131.03 and a 1-year high of $206.45. The company has a market cap of $49,800.57, a PE ratio of 19.46, a price-to-earnings-growth ratio of 1.54 and a beta of 0.49.

Cigna Corporation (NYSE:CI) last released its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating the consensus estimate of $2.36 by $0.47. Cigna Corporation had a net margin of 5.74% and a return on equity of 18.85%. The firm had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same period last year, the firm earned $1.94 EPS. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. equities research analysts predict that Cigna Corporation will post 10.34 earnings per share for the current year.

In other news, Chairman Isaiah Harris, Jr. sold 247 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Michael W. Triplett sold 10,417 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $197.77, for a total transaction of $2,060,170.09. Following the completion of the sale, the insider now owns 32,347 shares in the company, valued at $6,397,266.19. The disclosure for this sale can be found here. Over the last three months, insiders sold 12,471 shares of company stock worth $2,449,891. Insiders own 1.30% of the company’s stock.

Several brokerages recently commented on CI. Jefferies Group LLC increased their target price on shares of Cigna Corporation from $221.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. Royal Bank Of Canada reiterated an “outperform” rating and issued a $220.00 price target (up previously from $185.00) on shares of Cigna Corporation in a research note on Friday, November 3rd. Zacks Investment Research upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 price target for the company in a research note on Monday, October 9th. Piper Jaffray Companies reiterated a “buy” rating and issued a $191.00 price target on shares of Cigna Corporation in a research note on Sunday, September 17th. Finally, Credit Suisse Group began coverage on shares of Cigna Corporation in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 price target for the company. Three analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Cigna Corporation presently has a consensus rating of “Buy” and an average price target of $201.50.

TRADEMARK VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.watchlistnews.com/cigna-corporation-ci-holdings-raised-by-raymond-james-financial-services-advisors-inc/1721274.html.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.